2 completed, 2 terminated, 1 no longer available, 1 suspended. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 2 | Completed 1, Suspended 1 |
| Phase 1 | 1 | Completed 1 |
Follow SynCore Biotechnology Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX EndoTAG-1, Gemcitabine - Metastatic Pancreas Cancer, Locally Advanced Pancreatic Cancer | Phase 3 | Completed | SynCore Biotechnology Co., Ltd. | 218 | 2018-10-16 | 2023-05-06 |
| To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer SCB01A - Head and Neck Neoplasms | Phase 2 | Terminated | SynCore Biotechnology Co., Ltd. | 10 | 2017-04-30 | 2023-06-05 |
| A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer EndoTAG-1, Paclitaxel, Gemcitabine Hydrochloride - Triple-Negative Breast Cancer | Phase 3 | Suspended | SynCore Biotechnology Co., Ltd. | 420 | 2016-11-23 | 2023-04-26 |
| Study of SCB01A in Patient With Head and Neck Cancer SCB01A - Head and Neck Squamous Cell Carcinoma | Phase 2 | Terminated | SynCore Biotechnology Co., Ltd. | 5 | 2015-09-01 | 2023-06-27 |
| A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy SCB01A - Solid Tumors | Phase 1 | Completed | SynCore Biotechnology Co., Ltd. | 33 | 2011-04-01 | 2017-10-19 |
| Long-Term Compassionate Use Study for Continued Administration of SCB01A-01 SCB01A - Malignant Solid Tumour | No longer available | SynCore Biotechnology Co., Ltd. | 2020-11-17 |
Squamous Cell Carcinoma of Head and Neck (2) · Head and Neck Neoplasms (1) · Pancreatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Gemcitabine (2) · MBT-0206 (2) · Paclitaxel (1) · indole (1)
Taiwan (5) · France (1) · Hungary (1) · Israel (1) · Russia (1) · South Korea (1) · United States (1)
Her-Shyong Shiah, MD (1) · Hui-Hung Wang, MSc (1) · Li-Tzong Chen, M.D., Ph.D. (1) · Muh-Hwan Su, Ph.D. (1) · Tsu-Yi Chao, M.D., Ph.D. (1)